Zhan Wang Selected Research

Dyskinesias (Dyskinesia)

11/2023	Microstructural and functional alterations of the ventral pallidum are associated with levodopa-induced dyskinesia in Parkinson's disease.
1/2023	Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia.
8/2022	Risk factors for motor complications in female patients with Parkinson's disease.
5/2022	Effect of onset age on the levodopa threshold dosage for dyskinesia in Parkinson's disease.
1/2020	Risk thresholds of levodopa dose for dyskinesia in Chinese patients with Parkinson's disease: a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhan Wang Research Topics

Disease

75	Neoplasms (Cancer) 12/2024 - 08/2008
24	Neoplasm Metastasis (Metastasis) 06/2023 - 06/2010
18	Parkinson Disease (Parkinson's Disease) 01/2024 - 05/2016
17	Lung Neoplasms (Lung Cancer) 10/2023 - 10/2012
16	Osteosarcoma (Osteogenic Sarcoma) 10/2022 - 01/2016
12	Inflammation (Inflammations) 01/2023 - 07/2014
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 10/2012
9	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 02/2017
8	Tuberous Sclerosis (Bourneville's Disease) 01/2024 - 01/2021
7	Renal Cell Carcinoma (Grawitz Tumor) 08/2022 - 01/2019
7	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2015
6	Angiomyolipoma 01/2024 - 01/2021
5	Infections 04/2024 - 08/2011
5	Dyskinesias (Dyskinesia) 11/2023 - 01/2020
5	Carcinogenesis 01/2023 - 01/2018
5	Pain (Aches) 01/2023 - 11/2012
5	Fibrosis (Cirrhosis) 01/2023 - 01/2020
4	Spinal Cord Injuries (Spinal Cord Injury) 06/2023 - 01/2020
4	Disease Progression 01/2023 - 11/2020
4	Asthma (Bronchial Asthma) 12/2022 - 04/2014
4	Nasopharyngeal Carcinoma 11/2020 - 05/2009
3	Carcinoma (Carcinomatosis) 09/2023 - 01/2020
3	Spinal Cord Diseases 01/2023 - 02/2018
3	Cysts 01/2023 - 11/2020
3	Adenocarcinoma of Lung 01/2023 - 01/2018
3	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 11/2021
3	Echinococcosis (Hydatid Cysts) 01/2022 - 11/2020
3	Wounds and Injuries (Trauma) 10/2021 - 06/2014
3	Atherosclerosis 01/2021 - 01/2017
3	Ischemic Stroke 12/2020 - 05/2016
2	Orthostatic Hypotension (Postural Hypotension) 01/2024 - 10/2023
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2024 - 11/2020
2	Hemorrhage 12/2023 - 11/2017
2	Tremor (Tremors) 10/2023 - 01/2020
2	Adenoma (Adenomas) 09/2023 - 02/2017
2	Virus Diseases (Viral Diseases) 01/2023 - 12/2022
2	Immune System Diseases (Immune Disorders) 12/2022 - 12/2019
2	Hypertrophy 11/2022 - 11/2017
2	Hypoxia (Hypoxemia) 09/2022 - 04/2017
2	Osteoporosis 09/2022 - 12/2021
2	Pathologic Processes 08/2022 - 01/2020
2	Hypertension (High Blood Pressure) 01/2022 - 12/2020

Drug/Important Bio-Agent (IBA)

30	Biomarkers (Surrogate Marker)IBA 12/2024 - 11/2014
18	Proteins (Proteins, Gene)FDA Link 07/2023 - 08/2008
11	PlatinumIBA 03/2022 - 11/2014
8	trans-sodium crocetinate (crocetin)IBA 01/2024 - 01/2021
8	Levodopa (L Dopa)FDA LinkGeneric 01/2024 - 01/2020
8	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2019
7	LipidsIBA 01/2023 - 12/2019
6	Therapeutic UsesIBA 01/2024 - 03/2007
6	Long Noncoding RNAIBA 03/2023 - 01/2020
6	MicroRNAs (MicroRNA)IBA 01/2023 - 09/2018
4	RNA (Ribonucleic Acid)IBA 03/2023 - 01/2020
4	ChemokinesIBA 11/2022 - 01/2018
4	SynucleinsIBA 01/2022 - 05/2016
4	Alkaline PhosphataseIBA 01/2021 - 06/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2018
3	pembrolizumabIBA 03/2024 - 11/2022
3	CytokinesIBA 10/2023 - 01/2023
3	Triglycerides (Triacylglycerol)IBA 09/2022 - 01/2020
3	Cetuximab (Erbitux)FDA Link 01/2022 - 01/2019
3	VemurafenibIBA 01/2022 - 01/2019
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 01/2019
3	CholesterolIBA 01/2021 - 01/2020
3	Phosphotransferases (Kinase)IBA 01/2020 - 12/2018
2	Everolimus FDA Link 01/2024 - 01/2023
2	hydroxide ionIBA 01/2024 - 10/2023
2	AcidsIBA 01/2024 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023 - 08/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2023 - 01/2013
2	Oxygen (Dioxygen)IBA 03/2023 - 09/2022
2	Sirtuin 1IBA 01/2023 - 10/2021
2	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2023 - 10/2019
2	InflammasomesIBA 01/2023 - 01/2017
2	Interleukin-18 (Interleukin 18)IBA 01/2023 - 10/2022
2	Blood Proteins (Serum Proteins)IBA 01/2023 - 11/2022
2	Messenger RNA (mRNA)IBA 01/2023 - 04/2021
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2022 - 01/2020
2	Leucine (L-Leucine)FDA Link 10/2022 - 01/2017
2	Amino Acids FDA Link 10/2022 - 12/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 02/2021
2	Indicators and Reagents (Reagents)IBA 10/2022 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 10/2022 - 01/2021
2	Docetaxel (Taxotere)FDA Link 09/2022 - 10/2012
2	6-methyladenineIBA 08/2022 - 01/2020
2	N-methyladenosineIBA 08/2022 - 01/2020
2	Circular RNAIBA 06/2022 - 01/2021
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2022 - 11/2021

Therapy/Procedure

38	Drug Therapy (Chemotherapy) 03/2024 - 11/2014
28	Therapeutics 12/2023 - 03/2011
18	Immunotherapy 11/2023 - 01/2016
12	Radiotherapy 12/2023 - 01/2018
4	Decompression 12/2023 - 12/2014
3	Arthroplasty 06/2023 - 06/2019
3	Transplantation 05/2023 - 10/2021
3	Vagus Nerve Stimulation 01/2023 - 11/2018
3	Operative Surgical Procedures 10/2021 - 06/2014
3	Tonsillectomy 10/2020 - 01/2015
2	Photothermal Therapy 12/2022 - 10/2022
2	Photochemotherapy (Photodynamic Therapy) 05/2022 - 11/2021